The 2026 health basket includes significant news for cancer patients with advanced and innovative drugs. The budget allocated to oncology and hematology-oncology (blood cancers) has nearly doubled this year and represents 52% of the basket, totaling approximately 340 million shekels. The basket also includes significant news with the first-time inclusion of a drug for obesity treatment (Wegovy weight-loss injection), but the funding has been limited to adolescents aged 12-18 only. This is the first time the healthcare system has budgeted for a drug intended to treat obesity, which is defined globally as a disease.